BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AC
3801
DELISTED
Associated Capital Group
AC
| $1.75M | ﹤0.01% |
51,515
| – | – |
|
|
HSAI
3802
Hesai Group
HSAI
$2.7B
| $1.75M | ﹤0.01% |
417,853
+260,651
| +166% | +$1.24M |
|
3803
DHI Group
DHX
$185M
| $1.75M | ﹤0.01% |
835,829
-2,160,871
| -72% | -$5.01M |
|
3804
AtaiBeckley Inc
ATAI
$2.65B
| $1.74M | ﹤0.01% |
1,306,903
-94,533
| -7% | -$170K |
|
3805
Fractyl Health
GUTS
$110M
| $1.73M | ﹤0.01% |
406,199
+380,407
| +1,475% | +$2.45M |
|
3806
Relmada Therapeutics
RLMD
$540M
| $1.72M | ﹤0.01% |
573,314
-4,874
| -0.8% | -$17.6K |
|
|
ASRT
3807
DELISTED
Assertio
ASRT
| $1.72M | ﹤0.01% |
92,413
-330,991
| -78% | -$4.92M |
|
3808
Metagenomi Therapeutics
MGX
$45.2M
| $1.71M | ﹤0.01% |
420,242
+305,918
| +268% | +$2.1M |
|
3809
Context Therapeutics
CNTX
$55.5M
| $1.71M | ﹤0.01% |
+851,696
| New | +$1.47M |
|
|
WW
3810
DELISTED
WW International
WW
| $1.69M | ﹤0.01% |
1,447,277
-2,788,990
| -66% | -$4.64M |
|
3811
Transcontinental Realty Investors
TCI
$350M
| $1.69M | ﹤0.01% |
60,974
-1,728
| -3% | -$52K |
|
|
IMMP
3812
Immutep
IMMP
$54.7M
| $1.69M | ﹤0.01% |
839,081
+89,621
| +12% | +$240K |
|
|
SGMO
3813
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.69M | ﹤0.01% |
4,702,938
-8,574,699
| -65% | -$4.63M |
|
3814
State Street SPDR S&P China ETF
GXC
$474M
| $1.68M | ﹤0.01% |
24,592
| – | – |
|
3815
iShares MSCI Malaysia ETF
EWM
$324M
| $1.68M | ﹤0.01% |
74,844
+56,799
| +315% | +$1.28M |
|
3816
Eagle Bancorp Montana
EBMT
$190M
| $1.68M | ﹤0.01% |
126,648
-18,487
| -13% | -$239K |
|
3817
PUT
iShares MSCI Europe Financials ETF
EUFN
$4.24B
| $1.68M | ﹤0.01% |
+75,000
| New | +$1.72M |
|
3818
Criteo S.A. Ordinary Shares
CRTO
$1.11B
| $1.68M | ﹤0.01% |
44,446
+2,590
| +6% | +$94.8K |
|
3819
Alamos Gold
AGI
$11.6B
| $1.66M | ﹤0.01% |
106,050
-743
| -0.7% | -$11.6K |
|
3820
Expensify
EXFY
$178M
| $1.66M | ﹤0.01% |
1,110,882
-2,898,416
| -72% | -$4.57M |
|
3821
Nuveen Municipal Value Fund
NUV
$1.92B
| $1.65M | ﹤0.01% |
191,065
| – | – |
|
|
EVBN
3822
DELISTED
Evans Bancorp Inc
EVBN
| $1.64M | ﹤0.01% |
58,284
-281,638
| -83% | -$7.59M |
|
|
JBIO
3823
Jade Biosciences
JBIO
$1.15B
| $1.63M | ﹤0.01% |
28,088
+7,809
| +39% | +$5.18M |
|
|
DM
3824
DELISTED
Desktop Metal, Inc.
DM
| $1.62M | ﹤0.01% |
392,900
-1,616,812
| -80% | -$11.1M |
|
|
VIGL
3825
DELISTED
Vigil Neuroscience
VIGL
| $1.62M | ﹤0.01% |
405,043
-471,989
| -54% | -$1.62M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,441 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.